2599 studies found for:    "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Completed Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Acquired Bleeding Disorder;   Acquired Haemophilia
Intervention: Drug: activated recombinant human factor VII
22 Completed Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects
Conditions: Acquired Bleeding Disorder;   Acquired Haemophilia;   Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors;   Healthy
Intervention: Drug: activated recombinant human factor VII
23 Terminated Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery
Conditions: Cardiac Surgical Procedures;   Cardiopulmonary Bypass;   Blood Platelet Disorders;   Blood Coagulation Disorders
Intervention: Procedure: Platelet rich plasma sequestration
24 Recruiting Evaluating URMC's Massive Transfusion Protocol
Conditions: Blood Coagulation Disorders;   Trauma;   Acute Coagulopathy
Intervention: Other: Blood collection
25 Completed Cooperative Study of Factor VIII Inhibitors
Conditions: Blood Coagulation Disorders;   Hematologic Diseases;   Hemophilia A;   Hemorrhagic Disorders
Intervention: Drug: factor ix
26 Completed Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
Conditions: Hematologic Disease;   Blood Coagulation Disorders
Intervention: Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222)
27 Completed
Has Results
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A
Conditions: Blood Coagulation Disorders;   Hemophilia A
Interventions: Biological: Recombinant Factor VIII (BAY81-8973);   Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
28 Active, not recruiting Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
Conditions: Blood Coagulation Disorders;   Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
29 Not yet recruiting Comparison of Active and Passive Perioperative Warming Techniques in Reducing Intraoperative Blood Loss
Conditions: Hypothermia;   Blood Loss,;   Blood Coagulation Disorders
Intervention: Device: Bair Hugger forced air warming system
30 Completed CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
Conditions: Connective Tissue Diseases;   Blood Coagulation Disorders;   Leg Ulcers;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Systemic Scleroderma;   Mixed Connective Tissue Disease
Intervention:
31 Unknown  Study Using Plasma for Patients Requiring Emergency Surgery
Conditions: Hemorrhagic Shock;   Blood Coagulation Disorders;   Blood Products;   Trauma;   Ruptured AAA
Intervention: Drug: Human Plasma
32 Completed Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Other: omitting FFP transfusion before an intervention
33 Completed Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles
Condition: Blood Coagulation Disorders
Intervention:
34 Unknown  Evaluation of Menses in Congenital Bleeding Disorders
Conditions: Von Willebrand Disease;   Congenital Coagulation Factors Deficiency;   Haemophilia Carriers
Intervention:
35 Not yet recruiting Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
Conditions: Trauma;   Injury;   Bleeding;   Haemorrhage;   Coagulopathy
Interventions: Drug: Fibrinogen concentrate;   Drug: Placebo Comparator
36 Completed Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
Conditions: Liver Cirrhosis;   Coagulopathy
Interventions: Drug: Desmopressin;   Biological: blood transfusion
37 Completed Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
38 Completed Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Interventions: Drug: turoctocog alfa 2000 IU/vial;   Drug: turoctocog alfa 3000 IU/vial
39 Not yet recruiting To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors;   Relatives to/Carers of Patients
Intervention: Other: No treatment given
40 Completed A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B;   Healthy
Interventions: Drug: activated recombinant human factor VII, long acting;   Drug: placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years